OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE was reported 2035 times

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCOSAL ROUGHNESS 1 0.1429
1 SCATOLIA 1 0.0588
2 PRODUCT TAMPERING 71 0.0395
3 RESIDUAL SYMPTOM 1 0.0263
4 DEVICE DELIVERY SYSTEM ISSUE 705 0.0257
5 PERIPHERAL NERVE INFECTION 1 0.0244
6 TRACHEAL MASS 1 0.0161
7 PRODUCT CLOSURE ISSUE 8 0.0144
8 PRODUCT AFTER TASTE 13 0.0136
9 CARDIAC STEATOSIS 1 0.0135
10 COELIAC ARTERY COMPRESSION SYNDROME 1 0.0133
11 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
12 PLEUROPERICARDITIS 5 0.0121
13 CENTRAL NERVOUS SYSTEM STIMULATION 2 0.0113
14 DEVICE OCCLUSION 134 0.0095
15 FUNGAL RHINITIS 1 0.0093
16 LARYNGOPHARYNGITIS 1 0.0090
17 PRODUCT DELIVERY MECHANISM ISSUE 46 0.0085
18 UPPER RESPIRATORY TRACT IRRITATION 1 0.0081
19 PASTEURELLA INFECTION 1 0.0078
20 ADMINISTRATION SITE IRRITATION 1 0.0071
21 PRODUCT DEPOSIT 11 0.0071
22 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 1 0.0068
23 DRUG DOSE OMISSION BY DEVICE 520 0.0066
24 PRODUCT CONTAINER SEAL ISSUE 11 0.0063
25 NASAL CRUSTING 4 0.0062
26 FALSE POSITIVE INVESTIGATION RESULT 6 0.0059
27 SWELLING OF NOSE 1 0.0058
28 NASAL MUCOSAL DISORDER 3 0.0051
29 RIGHT ATRIAL ENLARGEMENT 1 0.0051
30 THYROID ADENOMA 1 0.0050
31 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 1 0.0048
32 PELVIC FLOOR DYSFUNCTION 1 0.0047
33 PARANASAL SINUS INFLAMMATION 1 0.0045
34 PRODUCT OUTER PACKAGING ISSUE 4 0.0044
35 NASAL ULCER 7 0.0044
36 NASAL ABSCESS 1 0.0043
37 CREST SYNDROME 1 0.0042
38 NASAL DRYNESS 26 0.0041
39 BODY MASS INDEX ABNORMAL 1 0.0041
40 LEUKOPLAKIA 1 0.0041
41 PRODUCT COMMUNICATION ISSUE 36 0.0041
42 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
43 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1 0.0039
44 RESPIRATORY MONILIASIS 1 0.0037
45 DEVICE DEFECTIVE 64 0.0037
46 RHINALGIA 10 0.0036
47 COR PULMONALE ACUTE 1 0.0036
48 SUSPECTED PRODUCT TAMPERING 2 0.0036
49 DRUG DELIVERY SYSTEM ISSUE 7 0.0035
50 INCREASED DOSE ADMINISTERED 1 0.0032
51 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 144 0.0031
52 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
53 NASAL DISCOMFORT 24 0.0030
54 OXYGEN SATURATION INCREASED 1 0.0029
55 GIARDIASIS 1 0.0029
56 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
57 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
58 RESPIRATORY TRACT OEDEMA 2 0.0027
59 HOUSEBOUND 1 0.0025
60 SINONASAL OBSTRUCTION 1 0.0025
61 RHINITIS ALLERGIC 11 0.0025
62 PRODUCT USE IN UNAPPROVED INDICATION 612 0.0025
63 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
64 HEART VALVE OPERATION 1 0.0023
65 PRODUCT USE ISSUE 431 0.0023
66 REFLUX LARYNGITIS 1 0.0023
67 ALLERGY TO PLANTS 1 0.0022
68 EXERCISE LACK OF 1 0.0021
69 ECZEMA NUMMULAR 1 0.0020
70 PRODUCT ODOUR ABNORMAL 21 0.0020
71 HERPES ZOSTER OTICUS 1 0.0020
72 TRANSPLANT EVALUATION 1 0.0020
73 DEVICE FAILURE 29 0.0019
74 NASAL INFLAMMATION 2 0.0019
75 PRODUCT CLEANING INADEQUATE 5 0.0019
76 PERIORBITAL CELLULITIS 1 0.0019
77 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
78 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
79 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
80 EYE INFECTION BACTERIAL 1 0.0018
81 DEVICE ISSUE 160 0.0018
82 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 52 0.0018
83 HAEMORRHAGIC OVARIAN CYST 1 0.0017
84 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
85 SINUS POLYP 1 0.0017
86 EPISTAXIS 125 0.0017
87 PRODUCT PRESCRIBING ISSUE 36 0.0017
88 DEVICE PHYSICAL PROPERTY ISSUE 12 0.0016
89 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
90 AUTOIMMUNE COLITIS 1 0.0016
91 HYPOGEUSIA 3 0.0015
92 NASAL DISORDER 4 0.0015
93 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
94 NASAL OPERATION 1 0.0015
95 DEVICE MECHANICAL ISSUE 20 0.0015
96 DEVICE MATERIAL ISSUE 3 0.0014
97 EAR SWELLING 3 0.0014
98 DRUG-DISEASE INTERACTION 1 0.0014
99 HYPOSMIA 2 0.0013
100 MYOPERICARDITIS 1 0.0013
101 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
102 EYELID FUNCTION DISORDER 1 0.0013
103 PRODUCT TASTE ABNORMAL 17 0.0013
104 INCORRECT DOSE ADMINISTERED BY DEVICE 32 0.0012
105 GIANT CELL ARTERITIS 1 0.0012
106 DENTAL DISCOMFORT 1 0.0012
107 DEAFNESS TRANSITORY 1 0.0012
108 CRANIOFACIAL FRACTURE 1 0.0012
109 ACUTE SINUSITIS 2 0.0012
110 TREATMENT DELAYED 2 0.0012
111 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
112 ELECTROCARDIOGRAM CHANGE 1 0.0011
113 WRONG SCHEDULE 1 0.0010
114 TONGUE OEDEMA 4 0.0010
115 PROSTATE INFECTION 1 0.0010
116 EYELID MARGIN CRUSTING 3 0.0010
117 ANIMAL SCRATCH 1 0.0010
118 SKIN OEDEMA 1 0.0010
119 MUCOSAL DRYNESS 2 0.0010
120 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
121 PERTUSSIS 1 0.0010
122 RESPIRATORY TRACT IRRITATION 1 0.0010
123 INFUSION SITE PRURITUS 3 0.0009
124 ALLERGY TO ANIMAL 1 0.0009
125 COLONOSCOPY 2 0.0009
126 AORTIC DILATATION 1 0.0009
127 DRY THROAT 9 0.0009
128 HALO VISION 1 0.0009
129 RHINITIS 7 0.0009
130 ADMINISTRATION SITE PAIN 1 0.0009
131 OPTIC NERVE INJURY 1 0.0009
132 SINUS PAIN 2 0.0009
133 MORBID THOUGHTS 1 0.0009
134 INTRUSIVE THOUGHTS 1 0.0008
135 SINUS OPERATION 2 0.0008
136 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
137 PHARYNGEAL INFLAMMATION 1 0.0008
138 LARYNGEAL OEDEMA 5 0.0008
139 POST-ACUTE COVID-19 SYNDROME 1 0.0008
140 BLOOD UREA DECREASED 1 0.0008
141 NASAL PRURITUS 1 0.0008
142 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
143 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
144 TONGUE DRY 1 0.0007
145 RECALLED PRODUCT ADMINISTERED 7 0.0007
146 HEAD TITUBATION 1 0.0007
147 RHONCHI 1 0.0007
148 APPLICATION SITE INFLAMMATION 1 0.0007
149 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
150 MAST CELL ACTIVATION SYNDROME 1 0.0007
151 PERIORBITAL SWELLING 4 0.0007
152 EJACULATION DISORDER 2 0.0007
153 CONNECTIVE TISSUE DISORDER 1 0.0007
154 OESOPHAGEAL STENOSIS 2 0.0007
155 NOROVIRUS INFECTION 1 0.0007
156 NORMOCYTIC ANAEMIA 1 0.0007
157 PAROSMIA 5 0.0007
158 EYE INJURY 2 0.0007
159 SEASONAL ALLERGY 9 0.0006
160 TESTICULAR PAIN 2 0.0006
161 COSTOCHONDRITIS 1 0.0006
162 OROPHARYNGEAL BLISTERING 1 0.0006
163 DENTAL IMPLANTATION 1 0.0006
164 NASAL POLYPS 3 0.0006
165 INTESTINAL POLYP 1 0.0006
166 TROPONIN I INCREASED 1 0.0006
167 BRONCHIECTASIS 4 0.0006
168 CERVICAL SPINAL STENOSIS 1 0.0006
169 FOOD CRAVING 3 0.0006
170 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
171 DEVICE BREAKAGE 23 0.0006
172 PURPURA 5 0.0006
173 INDURATION 1 0.0006
174 NASAL OEDEMA 1 0.0006
175 OROPHARYNGEAL DISCOMFORT 5 0.0006
176 ANOSMIA 8 0.0006
177 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
178 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
179 SNORING 2 0.0005
180 PARANASAL SINUS HYPERSECRETION 2 0.0005
181 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
182 OCULAR HYPERTENSION 1 0.0005
183 NASAL SEPTUM DEVIATION 1 0.0005
184 UNDERWEIGHT 1 0.0005
185 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
186 OESOPHAGEAL PAIN 2 0.0005
187 SINUS HEADACHE 3 0.0005
188 SYMPTOM RECURRENCE 3 0.0005
189 INTRACRANIAL ANEURYSM 2 0.0005
190 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
191 EYELID PAIN 1 0.0005
192 DEVICE DEPOSIT ISSUE 1 0.0005
193 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
194 CHEST INJURY 1 0.0005
195 POST PROCEDURAL DISCOMFORT 1 0.0005
196 LIP OEDEMA 2 0.0005
197 SPUTUM INCREASED 1 0.0005
198 PRODUCT PREPARATION ISSUE 3 0.0005
199 PRODUCT LOT NUMBER ISSUE 1 0.0005
200 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
201 PRODUCT LABEL ISSUE 3 0.0004
202 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
203 PERIARTHRITIS 1 0.0004
204 NECK SURGERY 1 0.0004
205 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
206 NASAL CONGESTION 25 0.0004
207 THROAT IRRITATION 19 0.0004
208 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
209 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
210 EYE OEDEMA 1 0.0004
211 DERMAL CYST 1 0.0004
212 RETINAL TEAR 1 0.0004
213 SUFFOCATION FEELING 1 0.0004
214 INABILITY TO AFFORD MEDICATION 4 0.0004
215 EYELID IRRITATION 1 0.0004
216 VENTRICULAR HYPERTROPHY 1 0.0004
217 ABDOMINAL INFECTION 1 0.0004
218 EAR DISCOMFORT 4 0.0004
219 MENOPAUSE 1 0.0004
220 DRUG TITRATION ERROR 1 0.0004
221 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
222 ASPHYXIA 3 0.0004
223 ORAL FUNGAL INFECTION 1 0.0004
224 EOSINOPHILIC OESOPHAGITIS 1 0.0004
225 MACULE 1 0.0004
226 SNEEZING 8 0.0004
227 SINUS DISORDER 7 0.0004
228 RESPIRATORY SYMPTOM 1 0.0004
229 PRODUCT CONTAINER ISSUE 3 0.0003
230 SKIN ATROPHY 2 0.0003
231 HYPERTONIC BLADDER 1 0.0003
232 SKIN SWELLING 3 0.0003
233 PRODUCT LABEL CONFUSION 2 0.0003
234 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
235 PULMONARY PAIN 1 0.0003
236 RESPIRATORY RATE INCREASED 3 0.0003
237 ACNE CYSTIC 1 0.0003
238 FIBROSIS 1 0.0003
239 AGEUSIA 8 0.0003
240 BLOOD BLISTER 1 0.0003
241 INFUSION SITE SWELLING 2 0.0003
242 PANCREATIC CARCINOMA STAGE IV 1 0.0003
243 DEVICE MALFUNCTION 22 0.0003
244 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
245 SKIN EROSION 1 0.0003
246 ASTHMA 35 0.0003
247 AUTOIMMUNE DISORDER 3 0.0003
248 RESPIRATORY TRACT INFECTION 8 0.0003
249 OTITIS MEDIA 1 0.0003
250 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
251 CANDIDA INFECTION 5 0.0003
252 TASTE DISORDER 6 0.0003
253 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
254 SUDDEN CARDIAC DEATH 1 0.0003
255 HEPATIC FIBROSIS 1 0.0003
256 APLASIA PURE RED CELL 1 0.0003
257 EYE DISCHARGE 3 0.0003
258 DEVICE USE ISSUE 5 0.0003
259 EAR PRURITUS 1 0.0003
260 LUNG TRANSPLANT 1 0.0003
261 HEAD DISCOMFORT 5 0.0003
262 PRODUCT CONTAMINATION 1 0.0003
263 DRY EYE 14 0.0003
264 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
265 LIVER TRANSPLANT 1 0.0003
266 ASTHMATIC CRISIS 1 0.0003
267 BLOOD PHOSPHORUS DECREASED 1 0.0003
268 VENTRICULAR ARRHYTHMIA 1 0.0003
269 CHRONIC SINUSITIS 1 0.0003
270 PRODUCT AVAILABILITY ISSUE 6 0.0003
271 RHINORRHOEA 17 0.0003
272 ACIDOSIS 2 0.0003
273 OESOPHAGEAL ULCER 1 0.0003
274 OROPHARYNGEAL PAIN 24 0.0003
275 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
276 EAR PAIN 5 0.0003
277 BRAIN FOG 4 0.0003
278 PRODUCT USE COMPLAINT 4 0.0003
279 HYPERPHAGIA 1 0.0003
280 OBSTRUCTION 1 0.0003
281 BLEPHARITIS 1 0.0002
282 INTENTIONAL DOSE OMISSION 7 0.0002
283 TRIGGER FINGER 1 0.0002
284 CONDITION AGGRAVATED 73 0.0002
285 SELF-INJURIOUS IDEATION 1 0.0002
286 EYE PRURITUS 8 0.0002
287 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
288 INFUSION SITE ERYTHEMA 2 0.0002
289 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
290 PURULENT DISCHARGE 1 0.0002
291 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
292 ABNORMAL SENSATION IN EYE 1 0.0002
293 DEVICE OPERATIONAL ISSUE 1 0.0002
294 HORDEOLUM 1 0.0002
295 GINGIVAL SWELLING 1 0.0002
296 WHEELCHAIR USER 1 0.0002
297 SINUSITIS 23 0.0002
298 BRAIN NEOPLASM MALIGNANT 1 0.0002
299 SOMNOLENCE 45 0.0002
300 SINUS CONGESTION 3 0.0002
301 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
302 CORONARY ARTERY OCCLUSION 3 0.0002
303 LUMBAR VERTEBRAL FRACTURE 1 0.0002
304 DYSPAREUNIA 1 0.0002
305 TINNITUS 10 0.0002
306 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
307 ORAL DISCOMFORT 3 0.0002
308 DYSGEUSIA 16 0.0002
309 COORDINATION ABNORMAL 3 0.0002
310 HEPATIC STEATOSIS 4 0.0002
311 ROSACEA 1 0.0002
312 SKIN ABRASION 1 0.0002
313 COLITIS MICROSCOPIC 1 0.0002
314 PRODUCT PACKAGING ISSUE 2 0.0002
315 GLAUCOMA 4 0.0002
316 PHARYNGEAL SWELLING 2 0.0002
317 VITREOUS FLOATERS 2 0.0002
318 BREATH SOUNDS ABNORMAL 1 0.0002
319 INJECTION SITE INFLAMMATION 1 0.0002
320 RASH MACULAR 7 0.0002
321 POOR QUALITY DEVICE USED 2 0.0002
322 DRUG TOLERANCE 1 0.0002
323 INSURANCE ISSUE 3 0.0002
324 SLUGGISHNESS 2 0.0002
325 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
326 ILLNESS 20 0.0002
327 MUSCULOSKELETAL CHEST PAIN 3 0.0002
328 POOR VENOUS ACCESS 2 0.0002
329 TONSILLITIS 1 0.0002
330 FOLLICULITIS 2 0.0002
331 SENSITIVITY TO WEATHER CHANGE 1 0.0002
332 ADVERSE DRUG REACTION 17 0.0002
333 RETCHING 4 0.0002
334 COMPRESSION FRACTURE 1 0.0002
335 GINGIVITIS 1 0.0002
336 PHARYNGITIS STREPTOCOCCAL 2 0.0002
337 ERYTHEMA OF EYELID 1 0.0002
338 DEVICE LEAKAGE 8 0.0002
339 ASTHENOPIA 1 0.0002
340 THERAPY INTERRUPTED 13 0.0002
341 DEAFNESS UNILATERAL 1 0.0002
342 HYPERKERATOSIS 1 0.0002
343 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
344 PRODUCT LEAKAGE 1 0.0002
345 ACUTE PULMONARY OEDEMA 1 0.0002
346 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
347 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
348 SCAB 2 0.0002
349 METABOLIC DISORDER 1 0.0002
350 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
351 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
352 DECREASED INTEREST 1 0.0002
353 ENERGY INCREASED 1 0.0002
354 ODYNOPHAGIA 1 0.0002
355 PIGMENTATION DISORDER 1 0.0002
356 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
357 PHARYNGITIS 2 0.0002
358 INJECTION SITE DISCOLOURATION 2 0.0002
359 SECRETION DISCHARGE 2 0.0002
360 SWELLING OF EYELID 1 0.0002
361 FEELING JITTERY 3 0.0002
362 FOREIGN BODY SENSATION IN EYES 1 0.0002
363 INTRAOCULAR PRESSURE INCREASED 2 0.0002
364 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
365 DYSPHONIA 9 0.0002
366 PLATELET COUNT INCREASED 2 0.0002
367 POLYP 1 0.0002
368 ASPERGILLUS INFECTION 1 0.0002
369 SOMNAMBULISM 1 0.0002
370 TOOTH INFECTION 2 0.0002
371 PRODUCT FORMULATION ISSUE 1 0.0002
372 APPETITE DISORDER 1 0.0002
373 EAR INFECTION 4 0.0002
374 DRUG INEFFECTIVE 198 0.0002
375 EYE HAEMORRHAGE 2 0.0001
376 POST-TRAUMATIC STRESS DISORDER 1 0.0001
377 ILL-DEFINED DISORDER 9 0.0001
378 FEEDING DISORDER 3 0.0001
379 DRY MOUTH 12 0.0001
380 PRODUCTIVE COUGH 7 0.0001
381 EYE MOVEMENT DISORDER 1 0.0001
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
383 HYPERSENSITIVITY 27 0.0001
384 HAIR GROWTH ABNORMAL 1 0.0001
385 HUNGER 2 0.0001
386 HAEMOPTYSIS 4 0.0001
387 PAPULE 1 0.0001
388 SINUS TACHYCARDIA 2 0.0001
389 RETINAL HAEMORRHAGE 1 0.0001
390 IMPAIRED QUALITY OF LIFE 2 0.0001
391 VISUAL FIELD DEFECT 1 0.0001
392 GASTROENTERITIS 2 0.0001
393 INTENTIONAL UNDERDOSE 1 0.0001
394 ORAL DISORDER 1 0.0001
395 DEVICE DIFFICULT TO USE 9 0.0001
396 DYSURIA 5 0.0001
397 WHEEZING 8 0.0001
398 HEART RATE IRREGULAR 3 0.0001
399 HYPOAESTHESIA ORAL 2 0.0001
400 OSTEOPENIA 2 0.0001
401 CONCUSSION 1 0.0001
402 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
403 PELVIC FRACTURE 1 0.0001
404 COUGH 36 0.0001
405 TREATMENT NONCOMPLIANCE 7 0.0001
406 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
407 OCULAR HYPERAEMIA 6 0.0001
408 RESPIRATORY TRACT CONGESTION 2 0.0001
409 EYE PAIN 7 0.0001
410 MYASTHENIA GRAVIS 1 0.0001
411 FRUSTRATION TOLERANCE DECREASED 1 0.0001
412 ABNORMAL FAECES 1 0.0001
413 EXPIRED PRODUCT ADMINISTERED 4 0.0001
414 SENSATION OF FOREIGN BODY 1 0.0001
415 FACE OEDEMA 2 0.0001
416 VITAMIN D DECREASED 1 0.0001
417 ERECTILE DYSFUNCTION 3 0.0001
418 VISION BLURRED 16 0.0001
419 MUSCULOSKELETAL DISCOMFORT 2 0.0001
420 NIGHTMARE 4 0.0001
421 CARDIAC MURMUR 1 0.0001
422 MIGRAINE 11 0.0001
423 GRIP STRENGTH DECREASED 1 0.0001
424 IMMUNOSUPPRESSION 1 0.0001
425 PRODUCT DOSE OMISSION ISSUE 33 0.0001
426 ANAL INCONTINENCE 1 0.0001
427 INCORRECT DOSE ADMINISTERED 25 0.0001
428 PNEUMONIA BACTERIAL 1 0.0001
429 RESPIRATORY DISTRESS 3 0.0001
430 PRODUCT DISTRIBUTION ISSUE 1 0.0001
431 ERYTHEMA MULTIFORME 1 0.0001
432 PHOTOPHOBIA 2 0.0001
433 SLEEP APNOEA SYNDROME 2 0.0001
434 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
435 HYPERCHOLESTEROLAEMIA 1 0.0001
436 PRODUCT QUALITY ISSUE 14 0.0001
437 PRODUCT STORAGE ERROR 9 0.0001
438 CHOKING 2 0.0001
439 SURGERY 6 0.0001
440 INFLAMMATORY BOWEL DISEASE 1 0.0001
441 THERAPY CHANGE 1 0.0001
442 BLOOD PRESSURE ABNORMAL 2 0.0001
443 HYPOTONIA 1 0.0001
444 BURNING SENSATION 7 0.0001
445 LACRIMATION INCREASED 3 0.0001
446 PRODUCT PHYSICAL ISSUE 2 0.0001
447 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
448 TOOTH ABSCESS 1 0.0001
449 EUPHORIC MOOD 1 0.0001
450 PRODUCT PREPARATION ERROR 2 0.0001
451 SWOLLEN TONGUE 3 0.0001
452 TENDERNESS 1 0.0001
453 URTICARIA 16 0.0001
454 INJECTION SITE DISCOMFORT 1 0.0001
455 SCRATCH 1 0.0001
456 IMPAIRED WORK ABILITY 2 0.0001
457 NIGHT SWEATS 3 0.0001
458 BIPOLAR DISORDER 1 0.0001
459 SKIN LACERATION 1 0.0001
460 PULMONARY THROMBOSIS 1 0.0001
461 OESOPHAGITIS 1 0.0001
462 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
463 TOOTH FRACTURE 1 0.0001
464 ANGIOEDEMA 4 0.0001
465 LIP SWELLING 3 0.0001
466 TOOTH DISORDER 2 0.0001
467 NERVE INJURY 1 0.0001
468 URINARY RETENTION 3 0.0001
469 HYPERTENSIVE CRISIS 1 0.0001
470 OCULAR DISCOMFORT 1 0.0001
471 CHEST DISCOMFORT 9 0.0001
472 DERMATITIS CONTACT 1 0.0001
473 MICTURITION URGENCY 1 0.0001
474 CHOLECYSTECTOMY 1 0.0001
475 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
476 EYE IRRITATION 5 0.0001
477 ADVERSE EVENT 8 0.0001
478 DEVICE USE ERROR 3 0.0001
479 ELECTROLYTE IMBALANCE 1 0.0001
480 SEXUAL DYSFUNCTION 1 0.0001
481 COVID-19 PNEUMONIA 1 0.0001
482 ACCIDENT 1 0.0001
483 HYPERLIPIDAEMIA 1 0.0001
484 IRRITABILITY 5 0.0001
485 HEADACHE 52 0.0001
486 BURSITIS 1 0.0001
487 ADRENAL INSUFFICIENCY 1 0.0001
488 DISCOMFORT 5 0.0001
489 LUNG DISORDER 4 0.0001
490 DYSPEPSIA 8 0.0001
491 CARDIOMEGALY 1 0.0001
492 SPINAL OPERATION 1 0.0001
493 TENDON RUPTURE 1 0.0001
494 INTENTIONAL PRODUCT MISUSE 7 0.0001
495 DYSPNOEA EXERTIONAL 3 0.0001
496 PRODUCT COMPLAINT 2 0.0001
497 INJECTION SITE IRRITATION 1 0.0001
498 EXPOSURE VIA SKIN CONTACT 2 0.0001
499 NODULE 1 0.0001
500 ECZEMA 4 0.0001
501 IMMUNE SYSTEM DISORDER 1 0.0001
502 SARS-COV-2 TEST POSITIVE 1 0.0001
503 INSOMNIA 20 0.0001
504 SWELLING 7 0.0001
505 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
506 DYSPNOEA 42 0.0001
507 THROAT TIGHTNESS 2 0.0001
508 LIMB INJURY 2 0.0001
509 TACHYPNOEA 1 0.0001
510 PNEUMONITIS 2 0.0001
511 DIZZINESS 36 0.0001
512 MEDICATION ERROR 4 0.0001
513 POLLAKIURIA 3 0.0001
514 APHONIA 1 0.0001
515 SKIN REACTION 1 0.0001
516 BLINDNESS UNILATERAL 1 0.0001
517 PAIN IN JAW 2 0.0001
518 FLATULENCE 4 0.0001
519 DIALYSIS 1 0.0001
520 BRONCHOSPASM 1 0.0001
521 SKIN BURNING SENSATION 5 0.0001
522 HERPES ZOSTER 4 0.0001
523 PARAESTHESIA ORAL 1 0.0001
524 BRONCHITIS 5 0.0001
525 CATARACT 4 0.0001
526 PULMONARY MASS 1 0.0001
527 COLITIS ULCERATIVE 3 0.0001
528 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
529 HAEMORRHAGE INTRACRANIAL 1 0.0001
530 THERAPY NON-RESPONDER 3 0.0001
531 HALLUCINATION 5 0.0001
532 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
533 STOMATITIS 4 0.0001
534 THYROID DISORDER 1 0.0001
535 ANKLE FRACTURE 1 0.0001
536 EJECTION FRACTION DECREASED 1 0.0001
537 DISEASE RECURRENCE 3 0.0001
538 HALLUCINATION, AUDITORY 1 0.0001
539 CYSTITIS 2 0.0001
540 SCIATICA 1 0.0001
541 COVID-19 11 0.0001
542 SENSORY DISTURBANCE 1 0.0001
543 HIP FRACTURE 2 0.0001
544 DRUG INTOLERANCE 6 0.0001
545 SWELLING FACE 4 0.0001
546 MANIA 1 0.0001
547 HEART RATE INCREASED 6 0.0001
548 PHOTOSENSITIVITY REACTION 1 0.0001
549 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
550 BLOOD PRESSURE DECREASED 4 0.0001
551 VIRAL INFECTION 2 0.0001
552 ABDOMINAL DISCOMFORT 10 0.0001
553 PERICARDITIS 1 0.0001
554 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
555 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
556 FATIGUE 45 0.0001
557 ABDOMINAL DISTENSION 6 0.0001
558 EOSINOPHILIA 1 0.0001
559 METASTASES TO LIVER 1 0.0001
560 SLEEP DISORDER 4 0.0001
561 GALLBLADDER DISORDER 1 0.0001
562 GASTROINTESTINAL DISORDER 5 0.0001
563 RASH PRURITIC 3 0.0001
564 LEUKOCYTOSIS 1 0.0001
565 RASH 24 0.0001
566 CONJUNCTIVITIS 1 0.0001
567 INFLUENZA 6 0.0001
568 EYE SWELLING 2 0.0001
569 NECK PAIN 3 0.0001
570 BACTERIAL INFECTION 1 0.0001
571 WEIGHT INCREASED 12 0.0001
572 MIDDLE INSOMNIA 1 0.0001
573 OXYGEN SATURATION DECREASED 3 0.0001
574 FOOT FRACTURE 1 0.0001
575 DYSPHAGIA 5 0.0001
576 GASTRIC ULCER 1 0.0001
577 DRY SKIN 7 0.0001
578 INCREASED APPETITE 1 0.0001
579 LETHARGY 3 0.0001
580 PULMONARY FIBROSIS 1 0.0001
581 LOWER LIMB FRACTURE 1 0.0001
582 PRURITUS 20 0.0001
583 CONTUSION 5 0.0001
584 ERUCTATION 1 0.0001
585 PALPITATIONS 6 0.0001
586 SKIN FISSURES 1 0.0001
587 KIDNEY INFECTION 1 0.0001
588 DISABILITY 1 0.0001
589 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
590 SYNCOPE 5 0.0000
591 CARDIAC FAILURE 4 0.0000
592 PRODUCT ADMINISTRATION ERROR 1 0.0000
593 PNEUMONIA 16 0.0000
594 EXTRA DOSE ADMINISTERED 2 0.0000
595 PSORIATIC ARTHROPATHY 2 0.0000
596 VERTIGO 3 0.0000
597 ANXIETY 14 0.0000
598 INFECTION 7 0.0000
599 DERMATITIS 1 0.0000
600 JOINT INJURY 1 0.0000
601 IRRITABLE BOWEL SYNDROME 1 0.0000
602 HYPERHIDROSIS 6 0.0000
603 HYPOACUSIS 2 0.0000
604 SKIN CANCER 1 0.0000
605 PRODUCT DISPENSING ERROR 1 0.0000
606 FEELING ABNORMAL 11 0.0000
607 HOSPITALISATION 7 0.0000
608 PERIPHERAL SWELLING 7 0.0000
609 PULMONARY OEDEMA 2 0.0000
610 ORAL PAIN 1 0.0000
611 RASH PAPULAR 1 0.0000
612 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
613 PERICARDIAL EFFUSION 1 0.0000
614 FALL 14 0.0000
615 PRODUCT PRESCRIBING ERROR 1 0.0000
616 RASH ERYTHEMATOUS 2 0.0000
617 MOBILITY DECREASED 3 0.0000
618 MENTAL IMPAIRMENT 1 0.0000
619 FIBROMYALGIA 1 0.0000
620 PRESYNCOPE 1 0.0000
621 NEURALGIA 1 0.0000
622 AGITATION 3 0.0000
623 PNEUMONIA ASPIRATION 1 0.0000
624 HAEMATEMESIS 1 0.0000
625 CARDIOVASCULAR DISORDER 1 0.0000
626 BLOOD PRESSURE INCREASED 6 0.0000
627 NAUSEA 31 0.0000
628 INJECTION SITE SWELLING 3 0.0000
629 ANAPHYLACTIC SHOCK 1 0.0000
630 NERVOUSNESS 2 0.0000
631 DEAFNESS 1 0.0000
632 SEDATION 1 0.0000
633 JOINT STIFFNESS 1 0.0000
634 DRUG INTERACTION 6 0.0000
635 CHEST PAIN 7 0.0000
636 HYPERTENSION 8 0.0000
637 BRADYCARDIA 2 0.0000
638 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
639 BREAST CANCER FEMALE 1 0.0000
640 FEAR 1 0.0000
641 PAIN OF SKIN 1 0.0000
642 FREQUENT BOWEL MOVEMENTS 1 0.0000
643 MALAISE 16 0.0000
644 INFLUENZA LIKE ILLNESS 3 0.0000
645 HAEMATOCHEZIA 2 0.0000
646 ANAPHYLACTIC REACTION 2 0.0000
647 DIVERTICULITIS 1 0.0000
648 RENAL IMPAIRMENT 3 0.0000
649 SKIN EXFOLIATION 3 0.0000
650 MYALGIA 6 0.0000
651 URINARY TRACT INFECTION 6 0.0000
652 DEPRESSION 8 0.0000
653 BALANCE DISORDER 3 0.0000
654 NEEDLE ISSUE 1 0.0000
655 ERYTHEMA 7 0.0000
656 ASCITES 1 0.0000
657 ABDOMINAL PAIN UPPER 7 0.0000
658 LABORATORY TEST ABNORMAL 1 0.0000
659 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
660 APHASIA 1 0.0000
661 CORONARY ARTERY DISEASE 1 0.0000
662 THERAPEUTIC RESPONSE DECREASED 2 0.0000
663 ACUTE KIDNEY INJURY 5 0.0000
664 INJECTION SITE RASH 1 0.0000
665 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
666 EMOTIONAL DISORDER 1 0.0000
667 LIMB DISCOMFORT 1 0.0000
668 VISUAL IMPAIRMENT 4 0.0000
669 HEAD INJURY 1 0.0000
670 HYPOTHYROIDISM 1 0.0000
671 ARTHRALGIA 13 0.0000
672 LOSS OF CONSCIOUSNESS 4 0.0000
673 PAIN 19 0.0000
674 ATRIAL FIBRILLATION 3 0.0000
675 IMPAIRED HEALING 1 0.0000
676 OSTEONECROSIS 1 0.0000
677 INFUSION RELATED REACTION 2 0.0000
678 INJECTION SITE PRURITUS 2 0.0000
679 ANGER 1 0.0000
680 HAEMATURIA 1 0.0000
681 INJECTION SITE REACTION 2 0.0000
682 PYREXIA 10 0.0000
683 HAEMORRHAGE 3 0.0000
684 HEART RATE DECREASED 1 0.0000
685 LYMPHADENOPATHY 1 0.0000
686 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
687 CRYING 1 0.0000
688 CONSTIPATION 6 0.0000
689 PANIC ATTACK 1 0.0000
690 NASOPHARYNGITIS 5 0.0000
691 HOT FLUSH 2 0.0000
692 ACNE 2 0.0000
693 DIARRHOEA 17 0.0000
694 DIABETES MELLITUS 2 0.0000
695 PLASMA CELL MYELOMA 1 0.0000
696 CHILLS 3 0.0000
697 INJECTION SITE BRUISING 2 0.0000
698 HYPOTENSION 5 0.0000
699 THROMBOSIS 2 0.0000
700 JOINT SWELLING 3 0.0000
701 OEDEMA PERIPHERAL 3 0.0000
702 BLINDNESS 1 0.0000
703 OSTEOPOROSIS 1 0.0000
704 CARDIAC ARREST 2 0.0000
705 TREMOR 4 0.0000
706 ROAD TRAFFIC ACCIDENT 1 0.0000
707 OSTEOARTHRITIS 1 0.0000
708 PSORIASIS 3 0.0000
709 MUSCULOSKELETAL STIFFNESS 2 0.0000
710 TACHYCARDIA 2 0.0000
711 SUICIDAL IDEATION 2 0.0000
712 NEPHROLITHIASIS 1 0.0000
713 SKIN DISCOLOURATION 1 0.0000
714 BACK PAIN 5 0.0000
715 WEIGHT DECREASED 6 0.0000
716 ABDOMINAL PAIN 5 0.0000
717 RENAL DISORDER 1 0.0000
718 BREAST CANCER 2 0.0000
719 BLOOD CHOLESTEROL INCREASED 1 0.0000
720 CARDIAC DISORDER 2 0.0000
721 ARRHYTHMIA 1 0.0000
722 INTERSTITIAL LUNG DISEASE 1 0.0000
723 LEUKOPENIA 1 0.0000
724 CELLULITIS 1 0.0000
725 FLUID RETENTION 1 0.0000
726 THERAPY CESSATION 1 0.0000
727 VOMITING 9 0.0000
728 MUSCULOSKELETAL PAIN 1 0.0000
729 DERMATITIS ATOPIC 1 0.0000
730 DEPRESSED MOOD 1 0.0000
731 DISTURBANCE IN ATTENTION 1 0.0000
732 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
733 OEDEMA 1 0.0000
734 ARTHROPATHY 1 0.0000
735 BLISTER 1 0.0000
736 PRODUCT SUBSTITUTION ISSUE 1 0.0000
737 SEIZURE 2 0.0000
738 DECREASED APPETITE 4 0.0000
739 BONE PAIN 1 0.0000
740 PLEURAL EFFUSION 1 0.0000
741 INJECTION SITE PAIN 5 0.0000
742 INJECTION SITE ERYTHEMA 2 0.0000
743 OFF LABEL USE 14 0.0000
744 DEVICE EXPULSION 1 0.0000
745 AMNESIA 1 0.0000
746 ALOPECIA 3 0.0000
747 NEOPLASM MALIGNANT 1 0.0000
748 RESPIRATORY FAILURE 1 0.0000
749 ASTHENIA 5 0.0000
750 CHRONIC KIDNEY DISEASE 1 0.0000
751 DEATH 11 0.0000
752 PARAESTHESIA 2 0.0000
753 TREATMENT FAILURE 1 0.0000
754 NO ADVERSE EVENT 2 0.0000
755 BLOOD GLUCOSE INCREASED 2 0.0000
756 PULMONARY EMBOLISM 1 0.0000
757 NEUROPATHY PERIPHERAL 1 0.0000
758 PAIN IN EXTREMITY 3 0.0000
759 FLUSHING 1 0.0000
760 HAEMOGLOBIN DECREASED 1 0.0000
761 SEPSIS 1 0.0000
762 THROMBOCYTOPENIA 1 0.0000
763 RHEUMATOID ARTHRITIS 1 0.0000
764 MUSCULAR WEAKNESS 1 0.0000
765 EMOTIONAL DISTRESS 1 0.0000
766 DEHYDRATION 1 0.0000
767 NEUTROPENIA 1 0.0000
768 HYPOAESTHESIA 1 0.0000
769 CONFUSIONAL STATE 1 0.0000
770 CEREBROVASCULAR ACCIDENT 1 0.0000
771 MYOCARDIAL INFARCTION 1 0.0000
772 MUSCLE SPASMS 1 0.0000
773 ANAEMIA 1 0.0000
774 GAIT DISTURBANCE 1 0.0000
775 OVERDOSE 1 0.0000